Kaufman David W, Kelly Judith P, Issaragrisil Surapol, Laporte Joan-Ramon, Anderson Theresa, Levy Micha, Shapiro Samuel, Young Neal S
Slone Epidemiology Center, Boston University, Boston, MA 02215, USA.
Am J Hematol. 2006 Jan;81(1):65-7. doi: 10.1002/ajh.20489.
Agranulocytosis and aplastic anemia are both rare, life-threatening blood dyscrasias. Agranulocytosis is mainly caused by medicines, whereas the etiology of aplastic anemia is largely unexplained. In two epidemiologic studies using the same methods, we observed a striking inverse relationship between the incidence of the two diseases in different regions, including five countries in Europe, and Israel and Thailand. The annual incidence of agranulocytosis ranged from 1.1 to 4.9 cases per million, and that of aplastic anemia, from 0.7 to 4.1 per million; the inverse correlation was consistent among the regions (R2 = 0.74). There is no clear explanation for this previously unreported pattern, but it seems unlikely to be due to methodology.
粒细胞缺乏症和再生障碍性贫血都是罕见的、危及生命的血液系统疾病。粒细胞缺乏症主要由药物引起,而再生障碍性贫血的病因大多不明。在两项采用相同方法的流行病学研究中,我们观察到在不同地区(包括欧洲的五个国家、以色列和泰国)这两种疾病的发病率之间存在显著的负相关关系。粒细胞缺乏症的年发病率为每百万人口1.1至4.9例,再生障碍性贫血为每百万人口0.7至4.1例;各地区之间这种负相关关系是一致的(R2 = 0.74)。对于这种此前未报告的模式尚无明确解释,但似乎不太可能是由于方法学问题。